The recent outbreak of severe acute respiratory syndrome (SARS), which is an acute respiratory illness, is caused by newly discovered SARS coronavirus (SARS-CoV). Herein we describe the antiviral activity of several classes of nucleoside analogues evaluated against SARS-CoV in Vero 76 cells, some of which exhibited moderate activity.
Severe acute respiratory syndrome (SARS) is a new form of non-typical pneumonia, which is caused by a new member of the coronaviridae family, the SARS-coronavirus (SARS-
. (Lee et al., 2003) .
To (Wenzel et al., 2003) . A synthetic nucleoside, ribavirin, has been studied in combination with corticosteroids and interferon-α for the treatment of SARS Koren et al., 2003; Morgenstern et al., 2005) . However, ribavirin has been shown to be only weakly active in vitro against SARS-CoV, and to even enhance and prolong viral replication in mice (Barnard et al., 2006) . Other agents such as isatine derivatives (Chen et al., 2005; Wu et al., 2005) , small interfering RNA (Wu et al., 2005) , glycyrrhizic acid derivatives (Hoever et al., 2005) , peptide inhibitors (Wu et al., 2004; Zhang et al., 2006) and natural compounds like Chinese medical herb extracts (Xiao et al., 2003; Zhong et al., 2003; Li et al., 2005) The nucleoside analogues listed ( Figure 1 ) were synthesized as described elsewhere (Choo et al., 2006; Gadthula et al., 2005; Chen et al., 2004; Chun et al., 2000; Song et al., 2001; Chu et al., 1991; Liang et al., 1997; Sureyya et al., 2001 D-(4-8) and L-(9-13) (4) uracil (5) adenine (6) inosine (7) guanine (8) OH OH B = uracil (9) cytosine (10) adenine (11) inosine (12) guanine (13) B S B = thymine (14) cytosine (15) adenine (16) guanine ( (24) thymine (25) cytosine (26) B = 5-C1-uracil (27) thymine (28) cytosine (29) uracil (30) adenine ( The 3′-fluoro-2′,3′-dideoxy-2′,3′-didehydro-4′-ethynyl-D-and L-furanosyl nucleosides (21-26) Interestingly, 
